Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2025-12-26 @ 11:47 AM
NCT ID:
NCT00315016
Eligibility Criteria:
Inclusion Criteria:
* documented diabetic renal disease with albuminuria \>0.020 g/L, stable renal function (i.e. increase of serum creatinine \<25% / 6 months), creatinine clearance \> 40 ml/min/1.73 m2 , in spite of maximal ACE-inhibition (40 mg fosinopril/day)
* blood pressure \< 140/90 mm Hg ( at baseline)
* serum potassium \< 5.0 mmol/l (at baseline).
Exclusion Criteria:
* use of NSAID's or immunosuppressive drugs
* use of ARBs, intolerance for ACE inhibition.
* use of diuretics that increase potassium such as triamterene, spironolactone or eplerenone
* pregnancy
* rash or cough on one on the drugs
* severe heart disease or instable angina
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00315016
Study Brief:
Protocol Section:
NCT00315016